Benefits
Immune system modulation and enhancement
Astragalus polysaccharides activate macrophages, NK cells, T-cells, and B-cells through multiple pattern recognition receptor pathways. Clinical studies show improved vaccine response, reduced upper respiratory infection frequency, and enhanced NK cell activity in immunocompromised and healthy elderly populations.
Telomerase activation and telomere preservation
Cycloastragenol and astragaloside IV activate telomerase reverse transcriptase (hTERT) — the enzyme that extends telomeres. A 12-month TA-65® study showed significant reduction in the percentage of critically short telomeres and improvements in immune aging biomarkers, positioning astragalus as one of very few natural telomerase activators with human clinical data.
Cardiovascular and kidney protection
Astragalus polysaccharides demonstrate protective effects in cardiac and renal tissue — reducing ischemia-reperfusion injury, improving cardiac function post-infarction, and reducing proteinuria in diabetic nephropathy. Multiple Chinese clinical trials (though often lower quality) support cardiovascular adjunct applications.
Blood sugar regulation
APS improves insulin sensitivity, reduces fasting blood glucose, and protects pancreatic beta cells from oxidative damage. Clinical studies in type 2 diabetic patients show significant improvements in glycemic markers with astragalus supplementation alongside conventional therapy.
Adaptogenic and anti-aging properties
Astragalus reduces cortisol levels under stress, improves energy and vitality, and has been used as a fundamental anti-aging herb in TCM. The combination of immune modulation, telomerase activation, antioxidant activity, and metabolic benefits makes astragalus one of the most comprehensive longevity-supporting botanicals.
Mechanism of action
TLR-4 and Dectin-1 immune receptor activation
Astragalus polysaccharides bind TLR-4 and Dectin-1 pattern recognition receptors on macrophages and dendritic cells, activating NF-κB-dependent innate immune responses including cytokine production, NK cell activation, and dendritic cell maturation. This innate immune priming enhances both infection defense and vaccine response efficacy.
Telomerase reverse transcriptase (hTERT) activation
Cycloastragenol activates hTERT transcription by binding and activating protein kinase C (PKC) signaling cascades that upregulate the TERT gene promoter. Astragaloside IV may act through similar mechanisms. Telomerase activation extends critically short telomeres in immune cells, potentially reversing one aspect of cellular immunosenescence.
PI3K/Akt/mTOR pathway modulation for cellular protection
Astragalosides modulate the PI3K/Akt survival pathway in cardiac, renal, and immune cells — reducing apoptosis in stressed cells, improving mitochondrial membrane potential, and supporting cellular energy metabolism under hypoxic or inflammatory conditions.
Clinical trials
Single-arm, open-label observational study of TA-65® (cycloastragenol-derived telomerase activator from Astragalus, 5–10 mg/day) in 114 healthy adults aged 53-87 over 12 months. Outcomes: telomere length distribution, T-cell immunosenescence markers (CD8+CD28- senescent cells), cytomegalovirus seropositivity. (Harley, Liu et al. 2011, Rejuvenation Res)
114 healthy adults aged 53-87. 12-month observational.
TA-65® reduced the percentage of critically short telomeres in peripheral blood lymphocytes vs baseline. Reduced CD8+CD28- senescent T-cell populations, particularly in CMV-seropositive subjects. Authors propose telomerase activation mechanism. Important limitations: open-label without placebo; 'critically short' telomere measure is specialized; the broader mean telomere length effect is more debated. Independent replications limited.
Systematic review of randomized controlled trials examining astragalus (Astragalus membranaceus) preparations for prevention and treatment of upper respiratory infections in adults and children. (Block & Mead 2003, Integr Cancer Ther; or related systematic reviews)
Pooled across multiple RCTs.
Astragalus supplementation associated with reduced frequency of upper respiratory infections and shortened duration of illness in most included studies. Heterogeneous formulations (root powder, decoction, standardized extract) and variable methodology limit pooled estimates. Immune-modulating effects (e.g., enhanced NK cell activity, T-cell proliferation) provide mechanistic plausibility. Best evidence supports astragalus as a complementary immunomodulator rather than acute treatment.